Expression of interleukin-6 family receptors in NK92 cells is regulated by cytokines and not through direct interaction with plasmodium falciparum-infected erythrocytes

Journal of Interferon and Cytokine Research

Volumn 33, Issue 2, 2013, Pages 65-71

  Böttger, Evelyn ^a   Grangeiro De Carvalho, Elisandra ^a   Meese, Stefanie ^a,b   Kun, Jürgen F J ^a   Esen, Meral ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; ERYTHROCYTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL MEMBRANE; CYTOKINE RECEPTOR GP130; CYTOKINES; ERYTHROCYTES; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTEIN BINDING; RECEPTOR, CILIARY NEUROTROPHIC FACTOR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84873665719     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0094     Document Type: Article

References (40)

1. Andersson LC, Gahmberg CG, Kimura AK, Wigzell H. 1978. Activated human T lymphocytes display new surface glyco-proteins. Proc Natl Acad Sci U S A 75:3455-3458. (Pubitemid 8395091)
2. Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME, Smyth MJ, Degli-Esposti MA. 2005. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 42:547-555. (Pubitemid 39655967)
3. Arase H, Lanier LL. 2004. Specific recognition of virus-infected cells by paired NK receptors. Rev Med Virol 14:83-93. (Pubitemid 38316008)
4. Artavanis-Tsakonas K, Riley EM. 2002. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 169:2956-2963. (Pubitemid 35013137)
5. Bryceson YT, March ME, Ljunggren HG, Long EO. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214:73-91. (Pubitemid 44707903)
6. Caligiuri MA. 2008. Human natural killer cells. Blood 112: 461-469.
7. Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H. 1996. Interleukin-6 family of cyto-kines induced activation of different functional sites expressed by gp130 transducing protein. J Biol Chem 271:14764-14772. (Pubitemid 26194955)
8. Clark IA, Budd AC, Alleva LM, Cowden WB. 2006. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5:85.
9. Crabé S, Guay-Giroux A, Tormo AJ, Duluc D, Lissilaa R, Guilhot F, Mavoungou-Bigouagou U, Lefouili F, Cognet I, Ferlin W, Elson G, Jeannin P, Gauchat JF. 2009. The IL-27 p28 subunit binds cy-tokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J Immunol 183:7692-7702.
10. de Carvalho EG, Böttger E, Hoang VT, Kremsner PG, Kun JF. 2011. Limited response of NK92 cells to Plasmodium falcipar-um-infected erythrocytes. Malar J 10:311.
11. Degli-Esposti MA, Smyth MJ. 2005. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5:112-124. (Pubitemid 40208901)
12. Demyanets S, Huber K, Wojta J. 2012. Vascular effects of gly-coprotein130 ligands-part I: pathophysiological role. Vascul Pharmacol 56:34-46.
13. Gallagher G, Stimson WH, Findlay J, al-Azzawi F. 1990. Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother 31:49-52. (Pubitemid 20045588)
14. Garbers C, Hermanns HM, Schaper F, Mü ller-Newen G, Grötzinger J, Rose-John S, Scheller J. 2012. Plasticity and crosstalk of Interleukin 6-type cytokines. Cytokine Growth Factor Rev 23:85-97.
15. Grangeiro de Carvalho E, Bonin M, Kremsner PG, Kun JF. 2011. Plasmodium falciparum-infected erythrocytes and IL-12/IL-18 induce diverse transcriptomes in human NK cells: IFN-a/b pathway versus TREM signaling. PLoS One 6:e24963.
16. Hirano T, Nakajima K, Hibi M. 1997. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 8:241-252. (Pubitemid 28202436)
17. Horowitz A, Riley EM. 2010. Activation of human NK cells by malaria-infected red blood cells. Methods Mol Biol 612:429-446.
18. Korbel DS, Schneider BE, Schaible UE. 2008. Innate immunity in tuberculosis: myths and truth. Microbes Infect 10:995-1004.
19. Kwiatkowski D. 1990. Tumour necrosis factor, fever and fatality in falciparum malaria. Immunol Lett 25:213-216. (Pubitemid 20260871)
20. Kwiatkowski D, Nowak M. 1991. Periodic and chaotic hostparasite interactions in human malaria. Proc Natl Acad Sci U S A 88:5111-5113. (Pubitemid 21914693)
21. Lanier LL. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495-502. (Pubitemid 351560518)
22. Liese J,Schleicher U,Bogdan C. 2008. The innate immune response against Leishmania parasites. Immunobiology 213:377-387.
23. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. 2007. Dendritic cells prime natural killer cells by transpresenting interleukin 15. Immunity 26:503-517. (Pubitemid 46602996)
24. Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Köck A, Micksche M, Malejczyk J, Schauer E, May LT, Sehgal PB. 1989. IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 143:1206-1209. (Pubitemid 19211348)
25. Mackintosh CL, Beeson JG, Marsh K. 2004. Clinical features and pathogenesis of severe malaria. Trends Parasitol 20:597-603. (Pubitemid 39446751)
26. Muller-Newen G. 2003. The cytokine receptor gp130: faithfully promiscuous. Sci STKE 2003:E40.
27. Oberg HH, Wesch D, Grussel S, Rose-John S, Kabelitz D. 2006. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+ CD25-and CD25high regulatory T cells. Int Immunol 18:555-563.
28. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL. 1993. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion. J Immunol 150:4844-4855. (Pubitemid 23150351)
29. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS, Beeson JG, Tavul L, Michon P, Mueller I, Scho-field L. 2009. Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 77:3033-3043.
30. Rovira-Vallbona E, Moncunill G, Bassat Q, Aguilar R, Machevo S, Puyol L, Quintó L, Menéndez C, Chitnis CE, Alonso PL, Dobaño C, Mayor A. 2012. Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Malar J 11:181.
31. Sarthou JL, Angel G, Aribot G, Rogier C, Dieye A, Toure Balde A, Diatta B, Seignot P, Roussilhon C. 1997. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cy-tokines, and their soluble receptors in West African patients with severe malaria. Infect Immun 65:3271-3276. (Pubitemid 27342410)
32. Schofield L, Grau GE. 2005. Immunological processes in malaria pathogenesis. Nat Rev Immunol 5:722-735. (Pubitemid 43086173)
33. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, Jiang Z, Chan J, Bartholomeu DC, Lauw F, Hall JP, Barber GN, Gazzinelli RT, Fitzgerald KA, Golenbock DT. 2011. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35:194-207.
34. Smyth MJ, Ortaldo Jr. 1991. Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J Immunol 146:1380-1384.
35. Trager W, Jensen JB. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
36. Wenisch C, Linnau KF, Looaresuwan S, Rumpold H. 1999. Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J Infect Dis 179:747-750. (Pubitemid 30016169)
37. Wognum AW, van Gils FC, Wagemaker G. 1993. Flow cyto-metric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells of humans and rhesus monkeys. Blood 81:2036-2043. (Pubitemid 23106717)
38. Wu X, Gowda NM, Gowda DC. 2010. Plasmodium falciparum: differential merozoite dose requirements for maximal production of various inflammatory cytokines. Exp Parasitol 127:202-207.
39. Wunderlich CM, Delić D, Behnke K, Meryk A, Ströhle P, Chaurasia B, Al-Quraishy S, Wunderlich F, Brüning JC, Wunderlich FT. 2012. Cutting edge: inhibition of IL-6 trans-signaling protects from malaria-induced lethality in mice. J Immunol 188:4141-4144.
40. Zohlnhöfer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, Heinrich PC. 1992. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett 306:219-22.